Laboratory automation

Society for Laboratory Automation and Screening (SLAS) Selects CytoTronics’ Pixel System for 2024 New Product Award

Retrieved on: 
Tuesday, March 5, 2024

CytoTronics, Inc. , a pioneer of semiconductor-based platforms for discovery in cell biology, is pleased to announce that their Pixel ™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).

Key Points: 
  • CytoTronics, Inc. , a pioneer of semiconductor-based platforms for discovery in cell biology, is pleased to announce that their Pixel ™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).
  • Award selection was announced at the SLAS2024 International Conference and Exhibition in Boston, MA on February 6th, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240305158077/en/
    CytoTronics' Pixel™ system received the 2024 New Product Award from the Society for Laboratory Automation and Screening (SLAS).
  • Front-runners are interviewed on-site at the conference by a panel of industry veterans with deep expertise in laboratory automation and screening techniques to determine final award recipients.

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

Retrieved on: 
Monday, February 12, 2024

Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.

Key Points: 
  • Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.
  • The award coincides with the first showing of Depixus’ ground-breaking MAGNA One™ instrument at the conference.
  • View the full release here: https://www.businesswire.com/news/home/20240212670326/en/
    Depixus CEO Gordon Hamilton receives the SLAS2024 Ignite Award from judge Severine Tamas-Lhoustau, CEO of Novoptim.
  • Depixus CEO Gordon Hamilton says, “We’re thrilled to have won this year’s Ignite Award against such stiff competition and congratulate all the other finalists.

Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

Retrieved on: 
Tuesday, February 6, 2024

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols.

Key Points: 
  • Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols.
  • As part of the agreement, Parse will sell a bundled solution composed of Evercode single cell reagents and an application-enabled INTEGRA Assist Plus instrument directly to customers.
  • As part of the deal, Parse customers will be supported by both the Parse Biosciences and INTEGRA field service and sales teams.
  • The Parse Biosciences team will be presenting a poster on the efficiency gained by integrating the INTEGRA Assist Plus with the Evercode protocols at the Society for Laboratory Automation and Screening (SLAS) conference in Boston February 3-7.

CytoTronics Reveals Pixel System to Monitor Live Cell Function at an Unprecedented Scale for Cell Biology Applications

Retrieved on: 
Monday, February 5, 2024

Pixel assesses live cell function at single-cell resolution, allowing scientists to simultaneously monitor cell viability, morphology, electrophysiology, metabolism, and more while generating electrical ‘images’ with single-cell spatial resolution.

Key Points: 
  • Pixel assesses live cell function at single-cell resolution, allowing scientists to simultaneously monitor cell viability, morphology, electrophysiology, metabolism, and more while generating electrical ‘images’ with single-cell spatial resolution.
  • Pixel delivers simultaneous multi-modal, high-resolution readouts in 96- or 384-well plates, enabling cell monitoring and data collection at unprecedented scale.
  • It’s widely applicable for in vitro cell biology applications including drug discovery, from target validation to toxicology screening.”
    CytoTronics’ early-access program for Pixel Primo empowers cell biologists to unlock applications that were previously inaccessible.
  • The early-access program includes applications for endothelial and epithelial cells, cancer cell biology, mechanism of action/toxicology, stem cell biology, cardiac function, and neural function.

Deepcell Unveils Innovative AI-Powered Single Cell Morphology Data at Leading Scientific Meetings

Retrieved on: 
Thursday, February 1, 2024

In addition, the company announced that its REM-I Platform is a finalist for the New Product Award at SLAS.

Key Points: 
  • In addition, the company announced that its REM-I Platform is a finalist for the New Product Award at SLAS.
  • “We look forward to sharing the tremendous progress we’ve made as a company with the scientific community at these meetings.
  • A year ago, we were presenting our first public datasets at AGBT and attending SLAS for the first time.
  • This year, we have the REM-I Platform in field testing, are presenting substantially more data, and look forward to the full commercialization of our instrument later this year,” said Maddison Masaeli, Ph.D., co-founder and chief executive officer at Deepcell.

Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management

Retrieved on: 
Friday, February 2, 2024

BURLINGTON, Mass., Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.

Key Points: 
  • BURLINGTON, Mass., Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.
  • The Ultra is an innovative evolution stemming from Azenta's well-established and industry-leading automated ultracold system product range.
  • "We are proud to launch the BioArc Ultra, a breakthrough solution that offers countless economic and environmental sustainability benefits to our customers across the sample management landscape," stated Dean Montano, Senior Product Manager for Azenta's Automated Storage Solutions.
  • Azenta undertakes no obligation to update the information contained in this press release.

Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award

Retrieved on: 
Tuesday, January 16, 2024

The New Venture Accelerator company was nominated for the Ignite Award Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition SLAS2024 to be held on February 3-6 in Boston, Massachusetts.

Key Points: 
  • The New Venture Accelerator company was nominated for the Ignite Award Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition SLAS2024 to be held on February 3-6 in Boston, Massachusetts.
  • "We are honored to be nominated for the prestigious Ignite Award and thankful for the extraordinary opportunity it offers us to exhibit on the Innovation AveNEW showcase at SLAS next month," said Tian.
  • This level of detail is impossible to achieve with 2D cultures or current iterations of 3D testing models."
  • To schedule a meeting with VivoSphere during SLAS, please contact Yuan Tian at [email protected] .

Asia-Pacific Laboratory Automation Market Analysis and Forecasts, 2023-2033: Increasing Opportunity for Laboratory Automation in Emerging Economies & Partnerships and Alliances

Retrieved on: 
Tuesday, January 9, 2024

DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "Asia-Pacific Laboratory Automation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "Asia-Pacific Laboratory Automation Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • Increasing scientific research, testing, and experimentation throughput, accuracy, reproducibility, and efficiency are the aims of laboratory automation.
  • The laboratory automation market in Asia-Pacific has been segmented into multiple product categories, encompassing liquid handling equipment, appliances, accessories, and software.
  • Competitive Strategy: The Asia-Pacific laboratory automation market is a highly fragmented market, with many smaller and private companies constantly entering the market.

CytoTronics' Breakthrough Semiconductor Platform Poised to Set New Standard in High-Throughput Phenotypic Screening for Drug Discovery

Retrieved on: 
Tuesday, December 12, 2023

The CytoTronics semiconductor platform captures an order of magnitude more information per biological sample than previous commercial techniques and will provide scientists with more front-end screening information.

Key Points: 
  • The CytoTronics semiconductor platform captures an order of magnitude more information per biological sample than previous commercial techniques and will provide scientists with more front-end screening information.
  • "Our platform represents a significant advancement in the world of high-throughput phenotypic screening,” stated Jeffrey Abbott, co-founder and CEO of CytoTronics.
  • "We believe that our platform has the potential to become an indispensable component of drug discovery and biomedical research,” stated Vince Wu, co-founder and CTO of CytoTronics.
  • Applications will include early-stage drug compound screening, downstream toxicity assays, immuno-oncology, and combining the techniques from the paper with electrophysiological measurements for cardiotoxicity and neuroscience applications.

Global Laboratory Automation Research Report 2023: Technology Advances and Growth Opportunities - Robotics and AI Enable a Paradigm Shift

Retrieved on: 
Friday, November 17, 2023

DUBLIN, Nov. 16, 2023 /PRNewswire/ -- The "Technology Advances and Growth Opportunities in Laboratory Automation" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 16, 2023 /PRNewswire/ -- The "Technology Advances and Growth Opportunities in Laboratory Automation" report has been added to ResearchAndMarkets.com's offering.
  • This report highlights the key players, the cutting-edge technologies they employ, and the broad range of applications of these solutions.
  • The technological advances in robotics, AI, microfluidic technologies, and sensors enable significant advancements in lab automation equipment capabilities, allowing various applications to adopt solutions across different sectors.
  • The improvements in the ease of use, competencies, and interoperability of lab software, especially LIMSs, enable the adoption of lab automation solutions.